Skip to main content

Dicyclomine Oral Presentations

Last Updated: October 21, 2022
Status: Current

Products Affected - Description
    • Dicyclomine hydrochloride capsule, Hikma, 10 mg, bottle, 100 count, NDC 00143-3126-01
    • Dicyclomine hydrochloride capsule, Hikma, 10 mg, bottle, 1000 count, NDC 00143-3126-10
    • Dicyclomine hydrochloride solution, Hikma, 10 mg/5 mL, 473 mL bottle, NDC 00054-0622-63
    • Dicyclomine hydrochloride tablet, Hikma, 20 mg, bottle, 100 count, NDC 00143-1227-01
    • Dicyclomine hydrochloride tablet, Hikma, 20 mg, bottle, 1000 count, NDC 00143-1227-10
    • Dicyclomine hydrochloride capsule, Mylan (Viatris), 10 mg, bottle, 100 count, NDC 00378-1610-01 - discontinued
    • Dicyclomine hydrochloride capsule, Mylan (Viatris), 10 mg, bottle, 500 count, NDC 00378-1610-05 - discontinued
    • Dicyclomine hydrochloride tablet, Mylan (Viatris), 20 mg, bottle, 100 count, NDC 00378-1620-01 - discontinued
    • Dicyclomine hydrochloride tablet, Mylan (Viatris), 20 mg, bottle, 500 count, NDC 00378-1620-05 - discontinued
    • Dicyclomine hydrochloride capsule, Teva, 10 mg, bottle, 100 count, NDC 00591-0794-01
    • Dicyclomine hydrochloride capsule, Teva, 10 mg, bottle, 1000 count, NDC 00591-0794-10
    • Dicyclomine hydrochloride tablet, Teva, 20 mg, bottle, 100 count, NDC 00591-0795-01
    • Dicyclomine hydrochloride tablet, Teva, 20 mg, bottle, 1000 count, NDC 00591-0795-10
Reason for the Shortage
    • Hikma did not provide a reason for the shortage.
    • Lannett has dicyclomine capsules and tablets available.
    • Mylan discontinued the 20 mg tablets in June 2021. The 10 mg tablet presentations were discontinued in 2022.
    • Par Pharmaceuticals has dicyclomine oral solution available.
    • Teva did not provide a reason for the shortage.
Available Products
    • Dicyclomine hydrochloride capsule, Lannett, 10 mg, bottle, 100 count, NDC 00527-0586-01
    • Dicyclomine hydrochloride capsule, Lannett, 10 mg, bottle, 1000 count, NDC 00527-0586-10
    • Dicyclomine hydrochloride tablet, Lannett, 20 mg, bottle, 100 count, NDC 00527-1282-01
    • Dicyclomine hydrochloride tablet, Lannett, 20 mg, bottle, 1000 count, NDC 00527-1282-10
    • Dicyclomine hydrochloride solution, Par Pharmaceuticals, 10 mg/5 mL, 473 mL bottle, NDC 00603-1161-58

Estimated Resupply Dates

    • Hikma has all dicyclomine oral presentations on allocation.
    • Teva has dicyclomine 10 mg capsules in 100-count and 20 mg tablets in 1,000-count bottles on back order, and the company estimates release dates of early-November 2022. The 20 mg tablets in 100-count bottles are on back order, and the company estimates a release date of late-October. The 10 mg capsules in 1,000-count bottles are on back order, and the company estimates a release date of mid-December 2022.

Updated

Updated October 21, 2022 by Anthony Trovato, PharmD, BCPS. Created January 22, 2019 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.